Why Might Biotechs Lose Easy Access to Scientific Papers?
Study Reveals No Evidence to Support Most European Cancer Drug Approvals
Biosimilars Struggle to Substitute Brand-Name Drugs
Update: The FDA Unanimously Recommends Approval of the First CAR-T Therapy
American CAR-T Leader Eyes Europe, Initiating Market Approval Process & Clinical Trial
Designer Babies in Europe: German Merck Set to Receive CRISPR Patent
French Biotech gets an EU CRISPR Patent for CAR-T Research
Update: France and the Netherlands deem Oxitec’s GM Mosquitoes Safe for Release
Cutting Through the BS in Biopharma: How To Spot Hype
The Brexit Effect: Salvaging Investment into UK Startups
Will Gene Editing Bypass the GMO Struggle or Worsen Public Distrust?
Way to Success: What Role does Company Culture Play in Biotech?
Labiotech UG, All Rights Reserved -
Send this to a friend